Dr. Amol Navathe, US Dept of Health and Human Services
Interviews
Advertisement
Katlyn Nemani, BA, Tufts University School of Medicine, discusses her paper
Advertisement
Dr. Deneen Vojta, UnitedHealthcare, discusses her paper and answers questions at the Healthcare Innovations and HIT Q&A Session at the National Press Club.
Dr. Aaron McKethan, US Dept of Health and Human Services, discusses his paper and answers questions at the National Press Club.
Dr. Melinda Beeuwkes Buntin, US Dept of Health and Human Services, discusses her papers and answers questions.
The Q&A Session from the Healthcare Innovations and HIT Q&A Session at the National Press Club in Washington, DC.
Advertisement
Dr. Sachin Jain, closes the Healthcare Innovations and HIT Q&A Session at the National Press Club in Washington, DC.
Dr. A Mark Fendrick welcomes the participants to the Healthcare Innovations and HIT Q&A Session at the National Press Club.
Dr. A. Mark Fendrick explains the concept of Value-Based Insurance Design (VBID) and how it works.
Suzette Kox, MPharm, Secretary General of the International Generic and Biosimilar Medicines Association (IGBA), discusses challenges faced jointly by the US and EU biosimilars markets.
Advertisement
Gillian Woollett, MA, DPhil, senior vice president, Avalere Health, discusses how confirming "sufficient likeness" in biosimilar development can and should replace the current "totality of the evidence” approach to biosimilar development.
Advertisement
Advertisement
Trending on AJMC
1
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology
2
Ontada Analysis Finds GLP-1 RA Use Linked to Improved Survival in Patients With Cancer
3
Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD
4
Orexin Agonist Shows Promise for Treating Narcolepsy, Hypersomnia: Richard Bogan, MD
5